Screener
AbbVie ABBV AOCI
AOCI at other companies
Other financials
Where this comes from
Reported directly by AbbVie in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The source filing: AbbVie’s 10-Q, filed May 8, 2026. Open the filing →
- Filed
- May 8, 2026, 12:28 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001551152-26-000017
FAQ
- What is AbbVie's AOCI?
- AbbVie (ABBV) reported AOCI of -$1.15B in Q1 2026.
- How has AbbVie's AOCI changed year-over-year?
- AbbVie's AOCI increased by 33.8% year-over-year, from -$1.74B to -$1.15B.
- What is the long-term trend for AbbVie's AOCI?
- Over 5 years (2020 to 2025), AbbVie's AOCI has grown at a -18.2% compound annual growth rate (CAGR), from -$3.12B to -$1.14B.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.
Ask your AI about AbbVie's aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude